关注
Reidar Fossmark
Reidar Fossmark
Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Techology
在 ntnu.no 的电子邮件经过验证
标题
引用次数
引用次数
年份
Long-term serotonin administration induces heart valve disease in rats
BI Gustafsson, K Tømmerås, I Nordrum, JP Loennechen, A Brunsvik, ...
Circulation 111 (12), 1517-1522, 2005
2932005
Rebound acid hypersecretion after long‐term inhibition of gastric acid secretion
R Fossmark, G Johnsen, E Johanessen, HL Waldum
Alimentary pharmacology & therapeutics 21 (2), 149-154, 2005
1502005
Gastric carcinoids after long‐term use of a proton pump inhibitor
CS Jianu, R Fossmark, T Viset, G Qvigstad, Ø Sørdal, R Mårvik, ...
Alimentary pharmacology & therapeutics 36 (7), 644-649, 2012
1472012
Adverse effects of proton pump inhibitors—evidence and plausibility
R Fossmark, TC Martinsen, HL Waldum
International journal of molecular sciences 20 (20), 5203, 2019
1412019
Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A
R Fossmark, Ø Sørdal, CS Jianu, G Qvigstad, IS Nordrum, M Boyce, ...
Alimentary pharmacology & therapeutics 36 (11-12), 1067-1075, 2012
1232012
Types of gastric carcinomas
HL Waldum, R Fossmark
International journal of molecular sciences 19 (12), 4109, 2018
1202018
Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint
HL Waldum, G Qvigstad, R Fossmark, PM Kleveland, AK Sandvik
Scandinavian journal of gastroenterology 45 (4), 389-394, 2010
1012010
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty
K Ausen, R Fossmark, O Spigset, H Pleym
Journal of British Surgery 102 (11), 1348-1353, 2015
982015
Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor
CS Jianu, OJ Lange, T Viset, G Qvigstad, TC Martinsen, R Fougner, ...
Scandinavian journal of gastroenterology 47 (1), 64-67, 2012
982012
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in …
AK Stunes, I Westbroek, BI Gustafsson, R Fossmark, JH Waarsing, ...
BMC endocrine disorders 11, 1-13, 2011
972011
The regulation of gastric acid secretion–clinical perspectives
HL Waldum, Ø Hauso, R Fossmark
Acta Physiologica 210 (2), 239-256, 2014
962014
Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition
R Fossmark, CS Jianu, TC Martinsen, G Qvigstad, U Syversen, ...
Scandinavian journal of gastroenterology 43 (1), 20-24, 2008
962008
Gastritis, gastric polyps and gastric cancer
H Waldum, R Fossmark
International journal of molecular sciences 22 (12), 6548, 2021
922021
Antiulcer drugs and gastric cancer
HL Waldum, B Gustafsson, R Fossmark, G Qvigstad
Digestive diseases and sciences 50, S39-S44, 2005
872005
Signet ring cells in gastric carcinomas are derived from neuroendocrine cells
K Bakkelund, R Fossmark, I Nordrum, H Waldum
Journal of Histochemistry & Cytochemistry 54 (6), 615-621, 2006
852006
The phylogeny and biological function of gastric juice—microbiological consequences of removing gastric acid
TC Martinsen, R Fossmark, HL Waldum
International journal of molecular sciences 20 (23), 6031, 2019
742019
Netazepide, a gastrin/cholecystokinin‐2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
M Boyce, AR Moore, L Sagatun, BN Parsons, A Varro, F Campbell, ...
British journal of clinical pharmacology 83 (3), 466-475, 2017
742017
Proton pump inhibitors (PPIs) may cause gastric cancer–clinical consequences
HL Waldum, Ø Sørdal, R Fossmark
Scandinavian journal of gastroenterology 53 (6), 639-642, 2018
622018
Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist
TC Martinsen, S Kawase, R Håkanson, SH Torp, R Fossmark, G Qvigstad, ...
Carcinogenesis 24 (12), 1887-1896, 2003
612003
Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids
CS Jianu, R Fossmark, U Syversen, Ø Hauso, V Fykse, HL Waldum
Scandinavian journal of gastroenterology 46 (4), 456-463, 2011
592011
系统目前无法执行此操作,请稍后再试。
文章 1–20